Kina papillary renal cell carcinoma

ʻO Kina Papillary Renal Cell Carcinoma: He Hōʻike Kūʻokoʻa Ka hoʻomaopopo ʻana iā Kina Papillary Renal Cell Carcinoma: He alakaʻi kikoʻī.

ʻO ka papillary renal cell carcinoma (PRCC) kahi ʻano o ka maʻi maʻi maʻi ʻaʻai i puka mai ma ka ʻili o nā tubules kidney. Hāʻawi kēia alakaʻi i kahi hiʻohiʻona piha o PRCC, e nānā pono ana i kona prevalence, diagnostics, treatment, and research in China. ʻOiai ʻike kikoʻī ma Kina papillary renal cell carcinoma kaupalena ʻia ma ka lehulehu, e ʻimi mākou i ka ʻike i loaʻa a me ka noiʻi honua kūpono e hāʻawi i kahi ʻike maopopo. No ka hoʻonaʻauao kēia ʻike a ʻaʻole ia he ʻōlelo aʻoaʻo olakino. E kūkākūkā mau me kekahi kauka lapaʻau kūpono no nā pilikia olakino a i ʻole ma mua o ka hoʻoholo ʻana e pili ana i kou olakino a lapaʻau paha.

ʻO ka Prevalence a me ka Risk Factors ma Kina

ʻIke pololei epidemiological ma Kina papillary renal cell carcinoma paʻakikī ka loaʻa ʻana ma muli o nā ʻano like ʻole o ka hōʻike a me nā ʻano hōʻiliʻili ʻikepili ma nā wahi like ʻole. Eia naʻe, ke piʻi aʻe nei ka nui o ka maʻi maʻi maʻi maʻi renal cell carcinoma (RCC) ma Kina, e hoʻohālikelike ana i nā ʻano honua. Hoʻopili ʻia kekahi mau mea pilikia me ka hoʻomohala ʻana o RCC, me:

ʻIke ʻia nā kumu pilikia no RCC

• Puhi paka
• ʻObesity
• Moʻolelo ʻohana o RCC
• ʻO ka ʻike ʻana i kekahi mau toxins
• ʻO ka maʻi Von Hippel-Lindau (VHL).

Pono e noiʻi hou aku e ʻike i nā kumu pilikia e pili ana i ka laha ʻana o PRCC i loko o ka heluna kanaka Kina.

ʻO ka hōʻailona o ka maʻi maʻi maʻi maʻi papillary

Hoʻopili maʻamau ka ʻike o PRCC i kekahi mau ʻano, e like me nā ʻano RCC ʻē aʻe:

Nā Hana Hoʻomaʻamaʻa

• Nā hoʻāʻo kiʻi: Hoʻohana ʻia nā CT scans, MRI scans, a me nā ultrasounds no ka ʻike ʻana i nā maʻi koko i loko o ka puʻupaʻa.
• Biopsy: Wehe ʻia kahi ʻāpana liʻiliʻi a nānā ʻia ma lalo o kahi microscope e hōʻoia i ka ʻike a hoʻoholo i ke ʻano kikoʻī o RCC (me PRCC).
• Nā hoʻāʻo koko: ʻOiai ʻaʻole ia he diagnostic ma o lākou iho, hiki i nā hoʻāʻo koko ke kōkua i ka nānā ʻana i ka hana ʻāʻī a ʻike i nā kiʻekiʻe kiʻekiʻe o kekahi mau mea e hōʻike ana i ka loaʻa ʻana o ka maʻi kanesa.

Nā Koho Lapaʻau no PRCC

ʻOkoʻa nā ala lapaʻau no PRCC ma muli o nā kumu like ʻole, me ke ʻano o ka maʻi kanesa, ke olakino holoʻokoʻa o ka mea maʻi, a me nā ʻano kikoʻī o ka ʻōpū. Loaʻa nā koho lapaʻau maʻamau:

ʻO nā ala lapaʻau

• ʻO ka ʻoki ʻana: ʻO ka wehe ʻana i ka ʻōpū (partial nephrectomy a i ʻole radical nephrectomy) ʻo ia ka lāʻau lapaʻau mua no PRCC kūloko.
• ʻO ka lāʻau lapaʻau i manaʻo ʻia: Hoʻohana ʻia nā lāʻau lapaʻau e hoʻopaʻa i nā molekole kikoʻī e pili ana i ka ulu ʻana o ka maʻi kanesa e hoʻolōʻihi a hoʻōki paha i ka piʻi ʻana o ka maʻi. ʻO nā laʻana he mea hoʻopaneʻe o ka vascular endothelial growth factor (VEGF) a me ka pahuhopu mammalian o rapamycin (mTOR).
• Immunotherapy: Hoʻohana kēia ʻano lapaʻau i ka ʻōnaehana pale o ke kino e hakakā ai i nā maʻi maʻi maʻi. ʻO nā mea hoʻopaneʻe Checkpoint kahi ala immunotherapy maʻamau no ka RCC kiʻekiʻe.
• ʻO ka lāʻau lapaʻau: Hoʻohana liʻiliʻi ʻia kēia ma PRCC akā hiki ke hoʻohana ʻia i kekahi mau kūlana.

Noiʻi a me nā kuhikuhi e hiki mai ana

Ke hoʻomau nei ka noiʻi e hoʻomaikaʻi i ka ʻike a me ka mālama ʻana iā PRCC. Ke nānā nei nā haʻawina ma:

Noi'i

• Ke ʻike nei i nā biomarkers hou no ka ʻike mua ʻana a me ka wānana.
• Ke hoʻomohala nei i nā lāʻau lapaʻau ʻoi aku ka maikaʻi a me ka liʻiliʻi o nā lāʻau ʻawaʻawa, me nā lāʻau lapaʻau pilikino.
• Ka hoʻomaopopo ʻana i ke kumu genetic a me ka molecular o PRCC e alakaʻi i nā hoʻoholo lapaʻau.

ʻO ka hui pū ʻana ma waena o nā hui noiʻi honua a me nā hui e like me ka Shandong Baofa Cancer Research Institute he mea koʻikoʻi no ka holomua ʻana i ko mākou ʻike Kina papillary renal cell carcinoma a me ka hoʻomaikaʻi ʻana i nā hopena maʻi ma ka honua holoʻokoʻa.

Hōʻole: Kuhi ʻia kēia ʻike no nā kumu hoʻonaʻauao wale nō a ʻaʻole pono e manaʻo ʻia he ʻōlelo aʻoaʻo olakino. Kūkākūkā mau me kekahi ʻoihana mālama ola no nā pilikia olakino.